Rapid Micro Biosystems Inc reports results for the quarter ended March 31 - Earnings Summary

• Rapid Micro Biosystems Inc RPID.OQ reported a quarterly adjusted loss of 26 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -31 cents. The mean expectation of three analysts for the quarter was for a loss of 27 cents per share.

• Revenue rose 28.4% to $7.21 million from a year ago; analysts expected $6.60 million.

• Rapid Micro Biosystems Inc's reported EPS for the quarter was a loss of 26 cents​.

• The company reported a quarterly loss of $11.26 million.

• Rapid Micro Biosystems Inc shares had fallen by 7.2% this quarter and gained 172.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 28.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Rapid Micro Biosystems Inc is $8.00

This summary was machine generated from LSEG data May 9 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)